Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer
Clinical trial NCT06571461 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06571461
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2028-01-01
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.